@prefix np: . @prefix npx: . @prefix ns1: . @prefix ns2: . @prefix ns3: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ns1:approve . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" . sub:_version prov:value "2"^^xsd:integer . sub:assertion prov:generatedAtTime "2023-07-20T09:47:10.754825"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377; prov:wasDerivedFrom . rdf:OBJECT rdfs:label "for the treatment of Cytokine release syndrome ( CRS ) or cytokine storm in India" . rdf:OBJECT-POSITION rdfs:label "(0, 8)" . rdf:PREDICATE rdfs:label "approved" . rdf:PREDICATE-POSITION rdfs:label "112" . rdf:SUBJECT rdfs:label "Steroids ( Methylprednisolone or Dexamethasone ) and Tocilizumab ( TCZ ) , an interleukin-6 receptor antagonist" . rdf:SUBJECT-POSITION rdfs:label "(0, 8)" . rdf:Statement rdfs:label "Steroids (Methylprednisolone or Dexamethasone) and Tocilizumab (TCZ), an interleukin-6 receptor antagonist, are approved for the treatment of Cytokine release syndrome (CRS) or cytokine storm in India." . rdfs:ABSTRACT-UID ns3:50 "9wycjlj5" . rdfs:TRIPLE-UID ns2:9wycjlj5-TRIPLE-ABSTRACT-1 "9wycjlj5-TRIPLE-ABSTRACT-1" . rdfs:label "treatment" . rdfs:label "steroids" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }